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LESSON OF THE MONTH
Confirmation of clinical diagnosis in requests for
prenatal prediction of SMA type I
J M Cobben, M de Visser, H Scheffer, J Osinga, G van der Steege, C H C M Buys,
G J van Ommen, L P ten Kate
Abstract
The recent discovery of a major SMA-
locus in the chromosomal region Sq
makes it possible to carry out prenatal
DNA studies in families in which a child
with SMA type I has been born. Since
direct mutation analysis is not yet possi-
ble, the reliability of prenatal prediction
of SMA type I usually depends on the
certainty of the clinical diagnosis in the
index patient. Sixteen requests were
received for DNA studies in couples who
had had a previous child with SMA type
I. After re-evaluation, the performance
of prenatal diagnosis was rejected in four
cases. Among the other twelve families
prenatal DNA analysis of chorion villus
biopsies has been carried out in three
families. In all three cases the fetus had
inherited the high-risk haplotypes from
both parents, and the parents chose to
terminate the pregnancy. An illustration
of the prenatal DNA studies in one family
is given. The importance of confirmation
of the diagnosis SMA type I before per-
forming DNA studies is emphasised.
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Proximal spinal muscular atrophies (SMA) of
childhood can be classified into three types on
the basis of clinical criteria, SMA type I
(Werdnig-Hoff:mann disease), SMA type II
(intermediate SMA) and SMA type III
(Kugelberg-Welander disease).' SMA type I
is a lethal, autosomal recessive disease with
a gene frequency of approximately
4-5/100,000.2 The clinical picture is charac-
terised by onset of hypotonia, progressive
weakness, wasting of limb and trunk muscles
and areflexia before six months of age.
Children with classic SMA type I never gain
the ability to sit, and death usually occurs
within two years due to respiratory insuffi-
ciency. The diagnosis is based on the charac-
teristic clinical picture, on signs of
denervation in EMG studies and on the
histopathological picture, that is, groups of
atrophic muscle fibres of either type in con-
junction with hypertrophic, usually predomi-
nantly type I, fibres. Inclusion and exclusion
criteria for the diagnosis of SMA type I have
recently been formulated.3 (Table)
In 1990 a major gene for the autosomal
recessive types of SMA type I, II and III was
localised in the chromosomal region 5ql2-
ql3.49 The availability of several highly poly-
morphic DNA-markers in this region permits
prenatal prediction of SMA type I by DNA
studies of chorionic villus or amniotic fluid
cells in families with an affected child, making
use of DNA from the affected child.'01'
Caution is necessary, however, because of the
probable genetic heterogeneity of SMA.58 12
We analysed the process of confirmation of
the clinical diagnosis in requests for prenatal
diagnosis ofSMA type I.
Methods
We restricted prenatal diagnosis to cases with
an unequivocal diagnosis of SMA type I
because of the reported genetic heterogeneity
of SMA types II and III.12 In all cases the
diagnosis SMA type I was evaluated by care-
ful analysis of clinical data 'and re-evaluation
of all available muscle biopsies.
When there was no doubt about the diag-
nosis of SMA type I, DNA from the parents
and all healthy siblings was isolated by routine
procedures, and DNA analysis was carried
out with markers available for the chromoso-
mal region 5ql 2-ql 3.'311'7
When both parents were informative for
Table Criteria for diagnosis ofSMA type I




2 Early onset and progressive course
age at onset < 1/2 year
age at death < 4 year
never able to sit unsupported
3 Creatine kinase normal
CK <1 Ox higher reference value)
4 Electromyographic study showing signs of anterior horn
cell involvement
5 Muscle biopsy compatible with anterior horn cell disease
6 Exclusion criteria:
no symptoms of other neurological systems
no sensory loss
no central motor neuron symptoms
no mental retardation
no arthrogryposis
no evident facial involvement
no other major organ involvement
In an isolated case all criteria except number 4 are obligate. In
a familial case only criteria 1, 2, 3 and 6 are obligate, while at
least one affected family member (sibling) must meet the cri-
teria for an isolated case.
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markers on both sides of the SMA-locus,
located between D5S6 and D5S 112, the
family was informed that prenatal diagnosis
was possible with a specified reliability,
dependent on the recombination distances of
informative probes, the number of investigat-
ed affected and healthy siblings and the pres-
ence or absence of consanguinity. We
incorporated in the calculations the current
best estimate of 5% for the proportion of
SMA type I families, which may not be due
to an autosomal recessive gene on 5ql2-ql3.
In a particular family this a priori estimated
figure of 5% was further modified for addi-
tional support for 5q-linkage, derived from
the family itself. Finally, the chance of errors
resulting from single and double recombina-
tions between the SMA-locus and the infor-
mative DNA-markers was incorporated.
Results
Sixteen requests for prenatal diagnosis of
SMA type I were received by our centre. In
4/16 cases prenatal diagnosis was declined
because the diagnosis did not fit classical
SMA type I. We describe these 4 cases, indi-
cating the differential diagnosis in the discus-
sion.
Case I
Case 1 was a male infant born with congeni-
tal contractures of all joints, telecanthus, gen-
eralised hypotonia and signs of respiratory
insufficiency. EMG-studies showed livelv
spontaneous muscle activity. Muscle biopsv
revealed extensive endomysial fibrosis. After
extensive clinical and biochemical studies
bacteriology and virology, chromosome stud-
ies, radiological and ultrasound examinations,
ECG and CT scanning of the cerebrum), no
diagnosis could be made and the child died at
the age of two months. Necropsy revealed an
obvious decrease in the anterior horn cells
with calcium deposits in these cells and the
diagnosis of Werdnig-Hoffmann disease was
made.
Case 2
Case 2 was a female infant born with congen-
ital contractures of arms and legs, hygroma
colli, a large atrial septal defect and gener-
alised hypotonia with fasciculation of the
tongue. She died when she was seven days
old of respiratory insufficiency. Necropsy
showed clear signs of anterior horn cell
involvement, and it was concluded that the
child had Werdnig-Hoffmann disease.
Case 3
This male child appeared normal at birth, but
in the first year hypotonia became evident.
The child could not sit unsupported. At one
year EMG-studies were normal, but a muscle
biopsy revealed groups of atrophic muscle
fibres, lying amidst groups of normal to large
calibre, predominantly type I, fibres. The
diagnosis of spinal muscular atrophy was then






Figure Prenatal diagnosis in family SMA54. 11-I was a boy with SMA type I, who died
in 1987. DNA was extractedfrom a frozen muscle biopsy, which had been stored. Both
parents were informative for DSS6, the father informative for MAPIB and the motherfor
D5S204. The fetus I-2 inherited the same haplotype from the parents as the affected child.
Assuming a genetic distance between DSS6 and MAPIB of2-4cM and between MAPIB
and 6741 of 4-6cM, and taking into account a 5% proportion of a priori non-5q-linked
SMA I-families, the risk of the fetus being affected with SMA type I was calculated to be
92-93%. The parents chose to terminate the pregnancy. * = male with SMA I.
0= female, healthy. 0 = chorionic villus biopsy. + = SMA-allele. -=normal allele.
Case 4
Case 4 was a male infant, noted to be pro-
gressively hypotonic at age one. There was
decreased facial muscle activity and knee
jerks were preserved. EMG studies revealed
no abnormalities. A muscle biopsy was per-
formed and a diagnosis of Werdnig-
Hoffmann disease was made. Re-evaluation
of the muscle biopsy, however, showed only a
slight variation in the size of the individual
muscle fibres, without groups of atrophic
fibres or other signs indicative of spinal mus-
cular atrophy.
In the remaining 12 families DNA-studies
were completed. In all families the parents
were informative for DNA-markers flanking
the SMA-gene. In 3 of the 12 families prena-
tal diagnosis by DNA-analysis of chorionic
villus biopsy material was performed. In all
three cases the fetus was probably affected
with SMA type I (with a risk of 90%,
92-93% and 94% respectively). The couples
opted for selective abortion before the fif-
teenth week of pregnancy. An example of one
family in which prenatal diagnosis was actual-
ly performed is represented in the figure.
Discussion
It is important to confirm the clinical diagno-
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avoid errors in prenatal diagnosis of this dis-
ease. The SMA gene itself has not yet been
found, so direct mutation DNA analysis is
impossible.
The four cases in the families not offered
prenatal diagnosis were considered not to
have classic SMsA type I.
Although contractures may develop during
the course of SMA type I (case 1), the associ-
ation of spinal muscular atrophy in children
with congenital arthrogryposis may represent
a separate disease entity.'8
The congenital contractures, cardiac
defect, hygroma colli and facial dysmorphia
in case 2 are all unusual signs in SMA type I.
Case 2 possibly represents a unique syn-
drome with signs of anterior horn disease,
and resembles another case which has been
documented.'9 Although the first pathologist
had diagnosed "Werdnig-Hoffnann disease"
this term is, often used erroneously, as a syn-
onym for anterior horn cell disease.20
The clinical course in case 3 does not fit a
diagnosis of SMA type I but could be consis-
tent with SMA type II. Genetic heterogeneity
for SMA type II is described with a propor-
tion of cases not autosomal recessive inherit-
ed but either due to phenocopies or to
autosomal dominant mutations.'2 Progressive
hypotonia in infancy (case 4) has a wide dif-
ferential diagnosis and the diagnosis in this
child is not yet clear.
The importance of confirming the clinical
diagnosis SMA before embarking on DNA
studies has recently been emphasised.320 It is
difficult to define rigid diagnostic criteria.
There will always be cases on which every
expert agrees that it must be SMA type I,
even though not all criteria (table 1) are met.
With the current availability of highly
informative CA- or GT-repeat DNA-mark-
ers, parental uniformativeness for all markers
in the 5ql2-13 region will be rare, and did
not occur in our cases. The DNA-studies will
therefore reveal whether or not the fetus has
inherited the same relevant portion of the
parental chromosomes 5 as the preceding
child with SMA did. A complicating factor is
that a recombinant between the flanking
markers of one or both parents may be
detected in prenatal DNA-studies. A single
recombination can greatly influence the risk
of the fetus being affected. Before prenatal
diagnosis, parents should be informed of the
possibility and probability of results like
these. The probabilities differ from family to
family, depending on the precise family situa-
tion and on which DNA-markers are infor-
mative. In most families, however, as long as
the gene has not been found, the reliability of
prenatal testing for SMA type I is mainly
dependent on the certainty of the clinical
diagnosis in the index patient.
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